Generic bioequivalence: a scientific consensus needed.
出版信息
Am Fam Physician. 1987 Feb;35(2):91, 95.
PMID:3812175
Abstract
摘要
相似文献
1
Generic bioequivalence: a scientific consensus needed.普通生物等效性：需要达成科学共识。
Am Fam Physician. 1987 Feb;35(2):91, 95.
2
Striving for standards in bioequivalence assessment: a review.生物等效性评估标准的探讨：综述
Int J Clin Pharmacol Ther Toxicol. 1991 Aug;29(8):293-8.
3
The integrity of generic drugs.仿制药的完整性。
Hosp Pract (Off Ed). 1989 Sep 15;24(9):9.
4
Generic vs. brand name drugs--defining and enforcing standards.
Internist. 1979 May;20(4):11, 13.
5
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.比较仿制药和创新药：对美国食品药品监督管理局12年生物等效性数据的综述
Ann Pharmacother. 2009 Oct;43(10):1583-97. doi: 10.1345/aph.1M141. Epub 2009 Sep 23.
6
Benefits and liabilities of generic prescribing.通用处方的益处与弊端。
W V Med J. 1972 Jun;68(6):161-6.
7
Determining drug equality.确定药物等效性。
FDA Consum. 1975 Nov;9(9):18-20.
8
The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?品牌药与仿制药之争：制药行业中是否存在生产质量更高药品的细分领域？
Contemp Pharm Pract. 1982 Spring;5(2):130-5.
9
How good are our drugs?我们的药物效果如何？
Am J Hosp Pharm. 1970 May;27(5):367-74.
10
Multinational medicines--ensuring drug quality in an era of global manufacturing.跨国药品——在全球生产时代确保药品质量。
N Engl J Med. 2009 Aug 20;361(8):737-40. doi: 10.1056/NEJMp0903870.
Zotero 插件